Publicação

Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1

Ver documento

Detalhes bibliográficos
Resumo:Cholesterol has a crucial role in central nervous system physiology and cell signaling, and many studies correlate alterations in brain cholesterol homeostasis with neurodegenerative diseases. The CYP46A1 gene codes for the cholesterol 24-hydroxylase (CYP46A1), a cytochrome P450 specifically expressed in neurons, that is responsible for the majority of brain cholesterol turnover. However, despite its physiological importance, the molecular mechanisms underlying the human CYP46A1 expression had not been characterized. Therefore, our work aimed to identify regulatory elements and factors involved the CYP46A1 brain-specific expression, and further assess if CYP46A1 transcription is regulated by epigenetic modifications, such as DNA methylation. Moreover, we aimed to identify a human cell model that could be a valuable tool for the study of cholesterol homeostasis in human neurons. In our initial studies, we cloned and characterized the human CYP46A1 promoter. Functional deletion analysis, over-expression studies, site-directed mutagenesis and gel-shift assays identified that not only Sp transcription factors control CYP46A1 transcription, but are most probably responsible for cell type specificity. To test our hypothesis that an increase in the (Sp3+Sp4)/ Sp1 ratio would result in CYP46A1 transcriptional activation, we differentiated Ntera2/clone D1 (NT2) human teratocarcinoma cells into post-mitotic neurons (NT2N). We demonstrated for the first time a significant increase in CYP46A1 mRNA and protein levels in a human cell culture, and identified a concomitant decrease in the levels of Sp1 associated with the proximal promoter of this gene. Nevertheless, we did not observe any conserved pattern in Sp protein binding to other Sp-regulated gene promoters, suggesting that Sp-DNA binding and transcriptional activity is highly dependent on the neuronal chromatin context. Moreover, we showed that throughout NT2 differentiation, HMG-CoA Abstract xxiv synthase, HMG-CoA reductase, SREBP2 and LDLr, key players in brain cholesterol homeostasis, present expression profiles that mimic what is thought to occur in vivo. Our results also suggest that progenitor cells eliminate cholesterol in the form of 27-hydroxycholesterol while neurogenesis induces a shift to the 24-hydroxylase-dependent elimination pathway. Finally, we showed that the demethylating agent 5’-Aza-2’-deoxycytidine (DAC) is a CYP46A1 inducer. Surprisingly, bisulfite sequencing analysis revealed that the CYP46A1 core promoter is completely unmethylated in both human brain and non-neuronal human tissues where CYP46A1 is not expressed. We demonstrated that DAC induces CYP46A1 expression, in a DNA methylation- independent mechanism, by decreasing Sp3/HDAC binding to the proximal promoter. Collectively, our results provide new insights on the regulatory circuits that control CYP46A1 transcription, and contribute to the identification of potential therapeutic approaches that can modulate CYP46A1 expression.
Autores principais:Silva, Inês Milagre da, 1980-
Assunto:Teses de doutoramento - 2011
Ano:2010
País:Portugal
Tipo de documento:tese de doutoramento
Tipo de acesso:acesso aberto
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1877771600384753664
author Silva, Inês Milagre da, 1980-
author_facet Silva, Inês Milagre da, 1980-
author_role author
contributor_name_str_mv Rodrigues, Elsa, 1969-
Gama, Maria João Carlos da Silva, 1958-
Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Silva, Inês Milagre da, 1980-\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Rodrigues, Elsa, 1969-
Gama, Maria João Carlos da Silva, 1958-
Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Silva, Inês Milagre da, 1980-
datacite.date.Accepted.fl_str_mv 2010-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2011-04-05T16:49:57Z
datacite.date.embargoed.fl_str_mv 2011-04-05T16:49:57Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Teses de doutoramento - 2011
datacite.titles.title.fl_str_mv Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
dc.contributor.none.fl_str_mv Rodrigues, Elsa, 1969-
Gama, Maria João Carlos da Silva, 1958-
Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Silva, Inês Milagre da, 1980-
dc.date.Accepted.fl_str_mv 2010-01-01T00:00:00Z
dc.date.available.fl_str_mv 2011-04-05T16:49:57Z
dc.date.embargoed.fl_str_mv 2011-04-05T16:49:57Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/3006
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Teses de doutoramento - 2011
dc.title.fl_str_mv Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_db06
description Cholesterol has a crucial role in central nervous system physiology and cell signaling, and many studies correlate alterations in brain cholesterol homeostasis with neurodegenerative diseases. The CYP46A1 gene codes for the cholesterol 24-hydroxylase (CYP46A1), a cytochrome P450 specifically expressed in neurons, that is responsible for the majority of brain cholesterol turnover. However, despite its physiological importance, the molecular mechanisms underlying the human CYP46A1 expression had not been characterized. Therefore, our work aimed to identify regulatory elements and factors involved the CYP46A1 brain-specific expression, and further assess if CYP46A1 transcription is regulated by epigenetic modifications, such as DNA methylation. Moreover, we aimed to identify a human cell model that could be a valuable tool for the study of cholesterol homeostasis in human neurons. In our initial studies, we cloned and characterized the human CYP46A1 promoter. Functional deletion analysis, over-expression studies, site-directed mutagenesis and gel-shift assays identified that not only Sp transcription factors control CYP46A1 transcription, but are most probably responsible for cell type specificity. To test our hypothesis that an increase in the (Sp3+Sp4)/ Sp1 ratio would result in CYP46A1 transcriptional activation, we differentiated Ntera2/clone D1 (NT2) human teratocarcinoma cells into post-mitotic neurons (NT2N). We demonstrated for the first time a significant increase in CYP46A1 mRNA and protein levels in a human cell culture, and identified a concomitant decrease in the levels of Sp1 associated with the proximal promoter of this gene. Nevertheless, we did not observe any conserved pattern in Sp protein binding to other Sp-regulated gene promoters, suggesting that Sp-DNA binding and transcriptional activity is highly dependent on the neuronal chromatin context. Moreover, we showed that throughout NT2 differentiation, HMG-CoA Abstract xxiv synthase, HMG-CoA reductase, SREBP2 and LDLr, key players in brain cholesterol homeostasis, present expression profiles that mimic what is thought to occur in vivo. Our results also suggest that progenitor cells eliminate cholesterol in the form of 27-hydroxycholesterol while neurogenesis induces a shift to the 24-hydroxylase-dependent elimination pathway. Finally, we showed that the demethylating agent 5’-Aza-2’-deoxycytidine (DAC) is a CYP46A1 inducer. Surprisingly, bisulfite sequencing analysis revealed that the CYP46A1 core promoter is completely unmethylated in both human brain and non-neuronal human tissues where CYP46A1 is not expressed. We demonstrated that DAC induces CYP46A1 expression, in a DNA methylation- independent mechanism, by decreasing Sp3/HDAC binding to the proximal promoter. Collectively, our results provide new insights on the regulatory circuits that control CYP46A1 transcription, and contribute to the identification of potential therapeutic approaches that can modulate CYP46A1 expression.
dirty 0
eu_rights_str_mv openAccess
format doctoralThesis
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/a286a682-2e27-4853-9fe0-4e6744890e70/download
id ul_39ed2f8a964b36d9582290e44744fa2a
identifier.url.fl_str_mv http://hdl.handle.net/10451/3006
inst_facet_str urn:organizationAcronym:ul{{{_:::_}}}Universidade de Lisboa
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/3006
organization_str_mv urn:organizationAcronym:ul
person_str_mv Silva, Inês Milagre da, 1980-
publishDate 2010
repo_facet_str urn:repositoryAcronym:ul{{{_:::_}}}Repositório da Universidade de Lisboa
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engporCholesterol has a crucial role in central nervous system physiology and cell signaling, and many studies correlate alterations in brain cholesterol homeostasis with neurodegenerative diseases. The CYP46A1 gene codes for the cholesterol 24-hydroxylase (CYP46A1), a cytochrome P450 specifically expressed in neurons, that is responsible for the majority of brain cholesterol turnover. However, despite its physiological importance, the molecular mechanisms underlying the human CYP46A1 expression had not been characterized. Therefore, our work aimed to identify regulatory elements and factors involved the CYP46A1 brain-specific expression, and further assess if CYP46A1 transcription is regulated by epigenetic modifications, such as DNA methylation. Moreover, we aimed to identify a human cell model that could be a valuable tool for the study of cholesterol homeostasis in human neurons. In our initial studies, we cloned and characterized the human CYP46A1 promoter. Functional deletion analysis, over-expression studies, site-directed mutagenesis and gel-shift assays identified that not only Sp transcription factors control CYP46A1 transcription, but are most probably responsible for cell type specificity. To test our hypothesis that an increase in the (Sp3+Sp4)/ Sp1 ratio would result in CYP46A1 transcriptional activation, we differentiated Ntera2/clone D1 (NT2) human teratocarcinoma cells into post-mitotic neurons (NT2N). We demonstrated for the first time a significant increase in CYP46A1 mRNA and protein levels in a human cell culture, and identified a concomitant decrease in the levels of Sp1 associated with the proximal promoter of this gene. Nevertheless, we did not observe any conserved pattern in Sp protein binding to other Sp-regulated gene promoters, suggesting that Sp-DNA binding and transcriptional activity is highly dependent on the neuronal chromatin context. Moreover, we showed that throughout NT2 differentiation, HMG-CoA Abstract xxiv synthase, HMG-CoA reductase, SREBP2 and LDLr, key players in brain cholesterol homeostasis, present expression profiles that mimic what is thought to occur in vivo. Our results also suggest that progenitor cells eliminate cholesterol in the form of 27-hydroxycholesterol while neurogenesis induces a shift to the 24-hydroxylase-dependent elimination pathway. Finally, we showed that the demethylating agent 5’-Aza-2’-deoxycytidine (DAC) is a CYP46A1 inducer. Surprisingly, bisulfite sequencing analysis revealed that the CYP46A1 core promoter is completely unmethylated in both human brain and non-neuronal human tissues where CYP46A1 is not expressed. We demonstrated that DAC induces CYP46A1 expression, in a DNA methylation- independent mechanism, by decreasing Sp3/HDAC binding to the proximal promoter. Collectively, our results provide new insights on the regulatory circuits that control CYP46A1 transcription, and contribute to the identification of potential therapeutic approaches that can modulate CYP46A1 expression.application/pdfporIdentification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1Silva, Inês Milagre da, 1980-Rodrigues, Elsa, 1969-Gama, Maria João Carlos da Silva, 1958-HostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@ulisboa.ptrepositorio@ulisboa.pt2011-04-05T16:49:57Z20102010-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/3006http://purl.org/coar/access_right/c_abf2open accessTeses de doutoramento - 20113998060 bytesliteraturehttp://purl.org/coar/resource_type/c_db06doctoral thesishttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/a286a682-2e27-4853-9fe0-4e6744890e70/downloadLisboa
spellingShingle Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
Silva, Inês Milagre da, 1980-
Teses de doutoramento - 2011
status SINGLETON
subject.fl_str_mv Teses de doutoramento - 2011
title Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
title_full Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
title_fullStr Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
title_full_unstemmed Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
title_short Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
title_sort Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1
topic Teses de doutoramento - 2011
topic_facet Teses de doutoramento - 2011
url http://hdl.handle.net/10451/3006
visible 1

Atividades financiadas

Não foram encontrados projetos financiados.